Drugs Affecting Platelet Function Tests

 

^* This review has been prepared upon invitation of the Working Party on Platelets of the International Committee on Thrombosis and Haemostasis.

• References

• 1 Aggeler P. M, O’Beilly R. A, Leong L, and Kowitz P. E. 1967; Potentiation of anticoagulant effect of warfarin by phenylbutazone. New England Journal of Medicine 276: 496.
• 2 Al-Mondhtry H, Marcus A. J, and Spaet T. H. 1970; On the mechanism of platelet function inhibition by acetyl salicylic acid. Proceedings of the Society for Experimental Biology and Medicine 133: 632.
• 3 Anderson K. W. 1964; A study of the gastric lesions induced by aspirin in laboratory animals. Archives Internationales de Pharmacodynamic et de Therapie 152: 379.
• 4 Arfors K.-E. 1973; Drugs, platelets and injury to the microcirculation. Canadian Medical Association Journal 108: 456.
• 5 Ball G, Brereton G. G, Fulwood M, Ireland D. M, and Yates P. 1970; Effect of Prostaglandin E₁ alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3’: 5’-cyclic monophosphate. Biochemical Journal 120: 709.
• 6 Baragar F. D, and Duthie J. J. R. 1960; Importance of aspirin as cause of anaemia and peptic ulcer in rheumatoid arthritis. British Medical Journal 1: 1106.
• 7 Beaumont J. L, Caen J, and Bernard J. 1955; Action hémorragipare de l’acide acétylsalicylique au cours des maladies du sang. Bulletin de la Société Médicale des Hôpitaux de Paris 71: 1087.
• 8 Benjamin S. P, and Hoffman G. C. 1972; “Aspirinated” platelets are hemostatic. New England Journal of Medicine 286: 784.
• 9 Bevan G. A. 1969. Essentials of Pharmacology. Hoeber Medical Division; New York:
• 10 Binder R. A, Durocher J, and Mielke C. H. 1971 The effect on the bleeding time in hemophilia of drugs commonly used for the treatment of pain. Abstracts in: Fourteenth Annual Meeting, American Society of Hematology, San Francisco, California, 1971.
• 11 Bleyer W. A, and Breckenridge R. T. 1970; Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis. Journal of the American Medical Association 213: 2049.
• 12 Bonnar J, and Walsh J. 1972; Prevention of thrombosis after pelvic surgery by British Dextran 70. Lancet 1: 614.
• 13 Borchgrevink C. F, and Waaler B. A. 1958; The secondary bleeding time. A new method for the differentiation of haemorrhagic diseases. Acta Medica Scandinavica 162: 361.
• 14 Borchgrevink C. F. 1961; Platelet adhesion in vivo in patients with bleeding disorders. Acta Medica Scandinavica 170: 231.
• 15 Born G. V. R. 1970; Observations on the change in shape of blood platelets brought about by adenosine diphosphate. Journal of Physiology 209: 487.
• 16 Boston Collaborative Drug Surveillance Program. 1974; Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. New England Journal of Medicine 290: 1158.
• 17 Bowie E. J. W, and Owen Jr. C. A. 1974. The bleeding time. In: Spaet T. H. (ed.). Progress in Hemostasis and Thrombosis. Grune and Stratton Inc.; New York: 249.
• 18 Breddin K. 1971; Discussion. Acta Medica Scandinavica, Supplementum 525: 224.
• 19 Brodle D. A, and Hooke K. F. 1971; Effects of route of administration on the production of gastric hemorrhage in the rat by aspirin and sodium salicylate. American Journal of Digestive Diseases 16: 985.
• 20 Bygdeman S. 1969; Prevention and therapy of thromboembolic complications with dextran. Progress in Surgery 7: 114.
• 21 Caprino L, Borrelli F, and Falchetti R. 1973; Effect of 4,5-diphenyl-2-bis-(2-hydroxyethyl) aminoxazol (Ditazol) on platelet aggregation, adhesiveness and bleeding-time. Arzneimittel-Forschung 23: 1277.
• 22 Cardamone J. M, Edson J. R, McArtur J. R, and Jacobs H. S. 1972; Abnormalities of platelet function in the myeloproliferative disorders. Journal of the American Medical Association 221: 270.
• 23 Carter A. E, Eban R, and Perrett R. D. 1971; Prevention of postoperative deep venous thrombosis and pulmonary embolism. British Medical Journal 1: 312.
• 24 Casteels-Van Daele M, and de Gaetano G. 1971; a Purpura and acetylsalicylic acid therapy. Acta Paediatrica Scandinavica 60: 203.
• 25 Casteels-Van Daele M, and de Gaetano G. 1971; b Haemorrhagic diathesis in children caused by aeetylsalicylic acid and other analgesics. Acta Medica Scandinavica, Supplement urn 525: 287.
• 26 Casteels-Van Daele M, Jaeken J, Eggermont E, de Gaetano G, and Vermylen J. 1972; More on the effects of antenatally administered aspirin on aggregation of platelets of neonates. Journal of Pediatrics 80: 685.
• 27 Clagett G. P, and Salzman E. W. 1974; Prevention of venous thromboembolism in surgical patients. New England Journal of Medicine 290: 93.
• 28 Conney A. H, and Burns J. J. 1962; Factors influencing drug metabolism. Advances in Pharmacology 1: 31.
• 29 Cooke A. R, and Gotjlston K. 1969; Failure of intravenous aspirin to increase gastrointestinal blood loss. British Medical Journal 3: 330.
• 30 Copley A. L. 1974; Bleeding time, other in vivo hemostasis tests and the arrest of hemorrhage. Thrombosis Research 4: 1.
• 31 Copley A. L, and Lalick J. J. 1942; Bleeding time, lymph time and clot resistance in man. Journal of Clinical Investigation 21: 145.
• 32 Corby D. G, and Schttlman I. 1971; The effects of antenatal drug administration on aggregation of platelets of newborn infants. Journal of Pediatrics 79: 307.
• 33 Croft D. N, Cuddigan J. H. P, and Sweetland C. 1972; Gastric bleeding and benorylate, a new aspirin. British Medical Journal 3: 545.
• 34 Croft D. N, and Wood P. H. N. 1967; Gastric mucosa and susceptibility to occult gastrointestinal bleeding caused by aspirin. British Medical Journal 1: 137.
• 35 Davies D.S, and Prichard B. N. C. (eds.) 1973. Biological Effects of Drugs in Relation to Their Plasma Concentrations. McMillan; London:
• 36 Davis J. W. 1974; Severe platelet dysfunction in a man with a normal bleeding time. American Journal of Clinical Pathology 61: 103.
• 37 Davison C, Hertig D. H, and De Vine R. 1966; Gastric hemorrhage induced by nonnarcotic analgetic agents in dogs. Clinical Pharmacology and Therapeutics 7: 239.
• 38 Day H. J, and Holmsen H. 1971; Concepts of the blood platelet release reaction. Series Haematologica 4: 3.
• 39 de Gaetano G, Bottecchia D, and Vermylen J. 1973; Retraction of reptilase-clots in the presence of agents inducing or inhibiting the platelet adhesion-aggregation reaction. Thrombosis Research 2: 71.
• 40 de Gaetano G, Casteels-Van Daele M, Claes J. H, and Eeckels R. 1971; a The effect of the ingestion of aeetylsalicylic acid on platelet function in normal children. Helvetica Paediatrica Acta 26: 423.
• 41 de Gaetano G, Donati M. B, and Vermylen J. 1971; b Some effects of indomethacin on platelet function, blood coagulation and fibrinolysis. International Journal of Clinical Pharmacology, Therapy and Toxicology 5: 196.
• 42 de Gaetano G, Franco R, Donati M. B, Bonaccorsi A, and Garattini G. 1974; Mechanical recording of reptilase-clot retraction. Effect of adenosine-5’ -diphosphate and prostaglandin E_x . Thrombosis Research 4: 189.
• 43 de Nicola P. 1962; Critical evaluation of methods for the study of blood coagulation, fibrinolysis and hemostasis. Thrombosis et Diathesis Haemorrhagica, 7, Supplementum 1: 325.
• 44 Didisheim P, Kazmier F. J, and Fuster V. 1974; Platelet inhibition in the management of thrombosis. Thrombosis et Diathesis Haemorrhagica 32: 21.
• 45 Donatelli L, and Marmo E. 1972; Emorragie digestive da farmaci e loro trattamento. La Clinica Terapeutica 62: 305.
• 46 Duke W. W. 1910; The relation of blood platelets to hemorrhagic disease: description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. Journal of the American Medical Association 55: 1185.
• 47 Edinburgh Hospitals Trial. 1974; Heparin versus dextran in the prevention of deep-vein thrombosis. A multi-unit controlled trial. Lancet 2: 118.
• 48 Eipe J. 1972; Drugs affecting therapy with anticoagulants. Medical Clinics of North America 56: 255.
• 49 Fox S, and West G. 1947; Vitamin K. and late tonsillar hemorrhage. Laryngoscope 57: 564.
• 50 Garattini S. 1968. Importance of knowledge of drug metabolism for the assessment of drug interactions. In: Tedeschi D. H, and Tedeschi R. E. (eds.) Importance of Fundamental Principles in Drug Evaluation. Raven Press; New York:
• 51 Green D, Dunne B, Schmid F. R, Rossi E. C, and Louis G. 1973; A study of the variable response of human platelets to collagen: relation to aspirin-induced inhibition of aggregation. American Journal of Clinical Pathology 60: 920.
• 52 Grossman M. L, Matsumoto K. K, and Lichter R. J. 1961; Fecal blood loss produced by oral and intravenous administration of various salicylates. Gastroenterology 40: 383.
• 53 Gröttum K. A. 1971. Electrophoretic investigations of blood platelets. In: Caen J. (ed.) Platelet Aggregation. Masson & Cie.; Paris: 199.
• 54 Hardisty R. M, and Hutton R. A. 1967; Bleeding tendency associated with “new” abnormality of platelet behaviour. Lancet 1: 983.
• 55 Harker L. A, and Slichter S. J. 1970; Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. New England Journal of Medicine 283: 1302.
• 56 Harker L. A, and Slichter S. J. 1972; The bleeding time as a screening test for evaluation of platelet function. New England Journal of Medicine 287: 155.
• 57 Harman R. E, Meisinger M. A. P, Davis G. E, and Kuehl F. A. 1964; The metabolites of indomethacin, a new anti-inflammatory drug. Journal of Pharmacology and Experimental Therapeutics 143: 215.
• 58 Haslam R. J. Inhibition of blood platelet function. In: Whitehouse M, and Scherer R. (eds.) Anti-inflammatory Agents, Chemistry and Pharmacology. Vol. 2 Academic Press; New York, San Francisco, London: 1974: 245.
• 59 Haslam R. R, Ekert H, and Gillam G. L. 1974; Hemorrhage in a neonate possibly due to maternal ingestion of salicylate. Journal of Pediatrics 84: 556.
• 60 Herrmann R. G. 1973; Effect of platelet aggregation inhibitors on bleeding time. Canadian Medical Association Journal 108: 454.
• 61 Herrmann R. G, Marshall W. S, Crowe V. G, Frank J. D, Marlett D. L, and Lacefield W. B. 1972; Effect of a new anti-inflammatory drug, fenoprofen, on platelet aggregation and thrombus formation. Proceedings of the Society for Experimental Biology and Medicine 139: 548.
• 62 Hirsh J, Street D, Cade J. F, and Amy H. 1973; Relation between bleeding time and platelet connective tissue reaction after aspirin. Blood 41: 369.
• 63 Hrodek O. 1966 Blood platelets in the newborn: their function in haemostasis and hemocoagulation. Acta Universitatis Carolinae Medica, Monographia no. 22.
• 64 Hurley J. W, and Crandall Jr. L. S. 1964; The effect of salicylates upon the stomachs of dogs. Gastroenterology 46: 36.
• 65 Hussar D. A. 1970; Oral anticoagulants - their interactions. Journal of the American Pharmaceutical Association NS 10: 78.
• 66 Ivey K. J. 1971; Acute haemorrhagic gastritis: modern concepts based on pathogenesis. Gut 12: 750.
• 67 Ivy A. C, Nelson D, and Bûcher G. 1941; The standardization of certain factors in the cutaneous “venostasis” bleeding time technique. Journal of Laboratory and Clinical Medicine 26: 1812.
• 68 Joist J. H, Cazenave J.-P, and Mustard J. F. 1973; The effect of barbituric acid derivatives on platelet function in vitro and in vivo. Thrombosis et Diathesis Haemorrhagica 30: 315.
• 69 Kalowski S, and Kincaid-Smith P. 1973; Interaction of dipyridamole with anticoagulants in the treatment of glomerulonephritis. Medical Journal of Australia 2: 164.
• 70 Kaneshiro M. M, Mielke Jr. C. H, Kasper C. K, and Rapaport S. I. 1969; Bleeding time after aspirin in disorders of intrinsic clotting. New England Journal of Medicine 281: 1039.
• 71 Kasper C. K, and Rapaport S. I. 1972; Bleeding times and platelet aggregation after analgesics in hemophilia. Annals of Internal Medicine 77: 189.
• 72 Kocsis J. J, Hernandovich J, Silver M. J, Smith J. B, and Ingerman C. 1973; Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins 3: 141.
• 73 Langman M. J. S. 1970; Epidemiological evidence for the association of aspirin and acute gastrointestinal bleeding. Gut 11: 627.
• 74 Leading Article. 1971; Anaesthetics and platelets. British Medical Journal 3: 597.
• 75 Leonards J. R. 1969; Absence of gastrointestinal bleeding following administration of salicylsalicylic acid. Journal of Laboratory and Clinical Medicine 74: 911.
• 76 Leonards J. R, and Levy G. 1970; Aspirin-induced occult gastrointestinal blood loss: local versus systemic effects. Journal of Pharmaceutical Sciences 59: 1511.
• 77 Leonards J. R, and Levy G. 1972; Effect of pharmaceutical formulation on gastrointestinal bleeding from aspirin tablets. Archives of Internal Medicine 129: 457.
• 78 Leonards J. R, Levy G, and Niemczura R. 1973; Gastrointestinal blood loss during prolonged aspirin administration. New England Journal of Medicine 289: 1020.
• 79 Levrat M, and Lambert R. 1960; Ulcères médicamenteux chez le rat. 3. L’acide acetyl-salicylique. Gastroenterologia 94: 273.
• 80 Loew D, Wellmer H.-K, Baer V, Merguet H, Rumpf P, Petersen H, Bromig G, Persch W. F, Marx F. J, and von Bary S. M. 1974; Postoperative Thromb-embolie-Prophylaxe mit Acetylsalicylsäure. Deutsche Medizinische Wochenschrift 99: 1.
• 81 Lynch A, Shaw H, and Milton G. W. 1964; Effect of aspirin on gastric secretion. Gut 5: 230.
• 82 Mannucci P. M, and Gorini S. (eds.) 1972. Platelet Function and Thrombosis. A Revieiv of Methods. Plenum Press; New York:
• 83 Mannucci P. M, and Pareti F. I. 1974 Platelet functions after intravenous administration in man of cyclic AMP and related drugs. Journal of Laboratory and Clinical Medicine, in press.
• 84 Mannucci P. M, Pareti F. I, and Ruggeri Z. M. 1974; Enhanced factor VIII activity in von Willebrand’s disease. New England Journal of Medicine 290: 1259.
• 85 Marchetti M, Vignati E, and Nicolis F. B. 1974; Gastrointestinal blood loss in patients receiving acetylsalicylic acid or diftalone, a new antiinflammatory drug: a comparative evaluation. Current Therapeutic Research 16: 742.
• 86 Mathew T. H, Kincaid-Smith P, Clyne D. H, Saker B. M, Nanra R. S, Morris P. J, and Marshall V. C. 1974; A controlled trial of oral anticoagulants and dipyridamole in cadaveric renal allografts. Lancet 1: 1307.
• 87 Maurer H. M, Still W. J. S, Caul J, Valdes O. S, and Laupus W. E. 1971; Familial bleeding tendency associated with microcytic platelets and impaired release of platelet adenosine diphosphate. Journal of Pediatrics 78: 86.
• 88 McCann W. P, McGowan E. I, Burnett O. L, and Palmisano P. A. 1970; Serum salicylate levels in blood donors. Journal of the American Medical Association 214: 753.
• 89 McKenzie F. N, Svensjö E, and Arfors K.-E. 1972; Effect of sodium pentobarbital anaesthesia on platelet behavior in vitro and in vivo. Microvascular Research 4: 42.
• 90 McNicol G. P, Mitchell J. R. A, Reuter H, and Van de Loo J. 1974; Platelets in Thrombosis. Their clinical significance and the evaluation of potential drugs. Thrombosis et Diathesis Haemorrhagica 31: 379.
• 91 Mielke Jr. C. H, and Britten A. F. H. 1970; Use of aspirin or acetaminophen in hemophilia. New England Journal of Medicine 282: 1270.
• 92 Mielke Jr. C. H, and Britten A. F. H. 1972; Aspirin: a new nightmare for blood bankers. New England Journal of Medicine 286: 268.
• 93 Mielke Jr. C. H, Kaneshiro M. M, Mäher I. A, Weiner J. M, and Rapaport S. I. 1969; The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 34: 204.
• 94 Mielke Jr. C. H, Ramos J. C, and Britten A. F. H. 1973; Aspirin as an antiplatelet agent: template bleeding time as a monitor of therapy. American Journal of Clinical Pathology 59: 236.
• 95 Mills D. G, Borda I. T, Philp R. B, and Eldridge C. 1974; Effects of in vitro aspirin on blood platelets of gastrointestinal bleeders. Clinical Pharmacology and Therapeutics 15: 187.
• 96 Minsker D. H, Jordan P. T, and MacMillan A. 1974. Inhibition of platelet aggregation by cyproheptadine. In: Sherry S, and Scriabine A. (eds.) Platelets and Thrombosis. Urban and Schwarzenberg; München: 161.
• 97 Morselli P. L, Garattini S, and Cohen S. N. (eds.) 1974. Drug Interactions. Raven Press; New York:
• 98 Mull M. M, and Hathaway W. E. 1970; Altered platelet function in newborns. Pediatric Research 4: 229.
• 99 Mustard J. F, and Packham M. A. 1970; Factors influencing platelet function: adhesion, release and aggregation. Pharmacological Reviews 22: 97.
• 100 Mustard J. F, and Packham M. A. 1973; Commentary. Drugs inhibiting platelet function. Biochemical Pharmacology 22: 3151.
• 101 Nadell J, Bruno J, Varady J, and Segre E. J. 1974; Effect of naproxen and of aspirin on bleeding time and platelet aggregation. Journal of Clinical Pharmacology 14: 176.
• 102 Naiman J. L, Bergman G, and Philippidis P. 1971 Severe gastrointestinal hemorrhage after therapeutic doses of aspirin in normal children. Abstract, American Pediatric Society and Society for Pediatric Research, Atlantic City, New Jersey, May 1971, p. 53.
• 103 Niewiarowski S, Regoeczi E, Stewart G. J, Senyi A. F, and Mustard J. F. 1972; Platelet interaction with polymerizing fibrin. Journal of Clinical Investigation 51: 685.
• 104 O’Brien J. R. 1968; Effects of salicylates on human platelets. Lancet 1: 779.
• 105 O’Brien J. R, Finch W, and Clark E. 1970; A comparison of an effect of different anti-inflammatory drugs on human platelets. Journal of Clinical Pathology 23: 522.
• 106 O’Brien J. R, Jamieson S, Etherington M, Klaber M. R, and Ainsworth J. F. 1973; Stressed template bleeding-time and other platelet-function tests in myocardial infarction. Lancet 1: 694.
• 107 O’Brien J. R, Tulevski V, Etherington M. 1971; Two in vivo studies comparing high and low aspirin dosage. Lancet 1: 399.
• 108 Okonkwo P, and Sise H. S. 1971; Effect of aspirin in vivo and in vitro on plasma cofactors of platelet aggregation. Thrombosis et Diathesis Haemorrhagica 25: 279.
• 109 Packham M. A, and Mustard J. F. 1974. Drug-induced alteration of platelet function. In: Baldini M. G, and Ebbe S. (eds.) Platelets: Production, Function, Transfusion and Storage. Gruñe and Stratton; New York, San Francisco, London: 1974.
• 110 Packham M. A, Warrior E. S, Glynn M. F, Senyi A. S, and Mustard J. F. 1967; Alteration of the response of platelets to surface stimuli by pyrazole compounds. Journal of Experimental Medicine 126: 171.
• 111 Palmisano P. A, and Cassady G. 1969; Salicylate exposure in the perinate. Journal American Medical Association 209: 556.
• 112 Pfeiffer C. J, and Lewandowski L. G. 1971; Comparison of gastric toxicity of acetylsalicylic acid with route of administration in the rat. Archives Internationales de Pharmacodynamic et de Thérapie 190: 5.
• 113 Pletscher A. 1968; Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. British Journal of Pharmacology 32: 1.
• 114 Pochedly C, and Ente G. 1972; Adverse hematologic effects of drugs. Pediatric Clinics of North America 19: 1095.
• 115 Praga C, Cortellaro M, and Pogliani E. 1972; Standardized bleeding time in the study of drugs interfering with platelet function. Advances in Experimental Medicine and Biology 34: 149.
• 116 Praga C, Malisardi P, Pollini C, Cortbllaro M, and Mars G. 1973; Bleeding time and antiaggregating drugs: a controlled study in elderly patients. Thrombosis Research 3: 13.
• 117 Prescott L. F. 1972. Antipyretic analgesics and drugs used in rheumatic diseases and gout. In: Meyler L, and Herxheimer A. (eds.) Side Effects of Drugs, Vol. 7. Excerpta Medica; Amsterdam: 138.
• 118 Quick A. J. 1966; Salicylates and bleeding: the aspirin tolerance test. American Journal of the Medical Sciences 252: 265.
• 119 Quick A. J. 1967; Acetylsalicylic acid as a diagnostic aid in hemostasis. American Journal of the Medical Sciences 254: 392.
• 120 Quick A. J. 1970. Bleeding Problems in Clinical Medicine. Saunders; Philadelphia:
• 121 Ratnoff O. D, and Bennett B. 1973; Clues to the pathogenesis of bleeding in von Willebrand’s disease. New England Journal of Medicine 289: 1182.
• 122 Rattazzi L, Haimov M. N, Glabman S, Papatestas A, Galernt I. M, and Burrows L. 1970; Role of the platelet in the obliterative vascular transplant rejection phenomenon. Surgical Forum 21: 241.
• 123 Reuter S. H, and Montgomery W. W. 1964; Aspirin versus acetaminophen after tonsillectomy. A comparative doubleblind clinical study. Archives of Otolaryngology 80: 214.
• 124 Ridolfo A. S, Rubin A, Crabtree R. E, and Gruber Jr. C. M. 1973; Effects of fenoprofen and aspirin on gastrointestinal microbleeding in man. Clinical Pharmacology and Therapeutics 14: 226.
• 125 Salzman E. W. 1972; Cyclic AMP and platelet function. New England Journal of Medicine 286: 358.
• 126 Salzman E. W, Harris W. H, and DeSanctis R. W. 1971; Reduction in venous thromboembolism by agents affecting platelet function. New England Journal of Medicine 284: 1287.
• 127 Sherry S, and Scriabine A. 1974. Platelets and Thrombosis. Urban and Schwarzenberg; München:
• 128 Shio H, and Ramwell P. W. 1972; Prostaglandin E! in platelet harvesting: an in vitro study. Science 175: 536.
• 129 Singer R. 1945; Acetylsalicylic acid, a probable cause for secondary post-tonsillectomy hemorrhage. Archives of Otolaryngology 42: 19.
• 130 Stavem P. 1974; Bleeding time from incisions standardized by protruding skin fold method. British Journal of Haematology 26: 153.
• 131 Stuart M. J, Murphy S, Oski F. A, Evans A. E, Donaldson M. H, and Gardner F. H. 1972; Platelet function in recipients of platelets from donors ingesting aspirin. New England Journal of Medicine 287: 1105.
• 132 Sullivan J. M, Harken D. E, and Gorlin R. 1971; Pharmacologic control of thromboembolic complications of cardiac-valve replacement. New England Journal of Medicine 284: 1391.
• 133 Sutor A. H, Bowie E. J. W, Thompson Jr. J. H, Didisheim P, Mertens B. F, and Owen Jr. C. A. 1971; Bleeding from standardized skin punctures: automated technic for recording time, intensity, and pattern of bleeding. American Journal of Clinical Pathology 5: 541.
• 134 Ueda I. 1971; The effects of volatile general anesthetics on adenosine diphosphate-induced platelet aggregation. Anesthesiology 34: 405.
• 135 Vermylen J, de Gaetano G, and Verstraete M. 1973. Platelets and thrombosis. In: Poller L. (ed.) Recent Advances in Thrombosis. Churchill Livingstone; London: 113.
• 136 Weiner M. 1973; Absorption, binding, metabolism, inactivation and excretion. Canadian Medical Association Journal 108: 447.
• 137 Weiss H. J. 1970; Aspirin ingestion compared with bleeding disorders. Search for a useful platelet antiaggregant. Blood 35: 333.
• 138 Weiss H. J. 1972. The pharmacology of platelet inhibition. In: Spaet T. H. (ed.) Progress in Hemostasis and Thrombosis. Grune and Stratton Inc.; New York: 199.
• 139 Willis A. L. 1974; a Isolation of a chemical trigger for thrombosis. Prostaglandins 5: 1.
• 140 Willis A. L. 1974; b An enzymatic mechanism for the antithrombotic and antihemo-static actions of aspirin. Science 183: 325.
• 141 Willoughby M. L.IST, and Allington M. J. 1961; The rate of blood loss from skin punctures during the Ivy bleeding time test. Journal of Clinical Pathology 14: 381.
• 142 Wood E. H, Prentice C. R. M, McGrouther D. A, Sinclair J, and McNicol G. P. 1973; Trial of aspirin and RA 233 in prevention of post-operative deep vein thrombosis. Thrombosis et Diathesis Haemorrhagica 30: 18.